I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Benda, Magdalena A.
13
results:
Search for persons
X
Format
Online (13)
Mediatypes
Articles (Online) (8)
OpenAccess-fulltext (5)
Sorted by: Relevance
Sorted by: Year
?
1
Attrition Rates in Multiple Myeloma Treatment under Real Wo..:
Benda, Magdalena A.
;
Ulmer, Hanno
;
Weger, Roman
...
Cancers. 15 (2023) 3 - p. 962 , 2023
Link:
https://doi.org/10.3390/..
?
2
SARS-CoV-2 RBD-specific and NP-specific antibody response o..:
Atzl, Michele
;
Muendlein, Axel
;
Winder, Thomas
...
BMJ Open. 12 (2022) 5 - p. e052130 , 2022
Link:
https://doi.org/10.1136/..
?
3
Serological SARS‐CoV‐2 antibody response, potential predict..:
Benda, Magdalena
;
Mutschlechner, Beatrix
;
Ulmer, Hanno
...
British Journal of Haematology. 195 (2021) 4 - p. 523-531 , 2021
Link:
https://doi.org/10.1111/..
?
4
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV..:
Zitt, Emanuel
;
Davidovic, Tamara
;
Schimpf, Judith
...
Frontiers in Immunology. 12 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
5
Efficacy and safety of heterologous booster vaccination wit..:
Reimann, Patrick
;
Ulmer, Hanno
;
Mutschlechner, Beatrix
...
British Journal of Haematology. 196 (2021) 3 - p. 577-584 , 2021
Link:
https://doi.org/10.1111/..
?
6
Efficacy and safety of tixagevimab/cilgavimab as passive im..:
Reimann, Patrick
;
Petzer, Verena
;
Mündlein, Axel
...
Annals of Hematology. 103 (2024) 6 - p. 2123-2131 , 2024
Link:
https://doi.org/10.1007/..
?
7
Safety of the oral factor XIa inhibitor asundexian compared..:
Piccini, Jonathan P
;
Caso, Valeria
;
Connolly, Stuart J
...
The Lancet. 399 (2022) 10333 - p. 1383-1390 , 2022
Link:
https://doi.org/10.1016/..
?
8
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV..:
Zitt, Emanuel
;
Davidovic, Tamara
;
Schimpf, Judith
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242233/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
9
Attrition Rates in Multiple Myeloma Treatment under Real Wo..:
Magdalena A. Benda
;
Hanno Ulmer
;
Roman Weger
...
Cancer Therapy. , 2023
Link:
https://doi.org/10.3390/..
?
10
Attrition Rates in Multiple Myeloma Treatment under Real Wo..:
Magdalena A. Benda
;
Hanno Ulmer
;
Roman Weger
...
https://www.mdpi.com/2072-6694/15/3/962. , 2023
Link:
https://doi.org/10.3390/..
?
11
SARS-CoV-2 RBD-specific and NP-specific antibody response o..:
Alois Lang
;
Axel Muendlein
;
Heinz Drexel
...
https://bmjopen.bmj.com/content/12/5/e052130.full. , 2022
Link:
https://doi.org/10.1136/..
?
12
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV..:
Emanuel Zitt
;
Tamara Davidovic
;
Judith Schimpf
...
https://www.frontiersin.org/articles/10.3389/fimmu.2021.704773/full. , 2021
Link:
https://doi.org/10.3389/..
?
13
Lipid Diffusion in Giant Unilamellar Vesicles Is More than ..:
Przybylo, Magdalena
;
Sýkora, Jan
;
Humpolíčková, Jana
...
Langmuir. 22 (2006) 22 - p. 9096-9099 , 2006
Link:
https://doi.org/10.1021/..
1-13
